Rafferty Asset Management
CAPR icon

Rafferty Asset Management’s Capricor Therapeutics CAPR Stock Holding History

Rafferty Asset Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
+62,353
New +$1.66M 0.01% 623
2025
Q3 		– Sell
-47,946
Closed -$476K – 1112
2025
Q2 		$476K Sell
47,946
-35,042
-42% -$370K ﹤0.01% 900
2025
Q1 		$788K Sell
82,988
-43,323
-34% -$601K ﹤0.01% 789
2024
Q4 		$1.74M Buy
+126,311
New +$2.21M 0.01% 683

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Rafferty Asset Management's CAPR Position: Q1 2026 in Review

Rafferty Asset Management opened a new position in Capricor Therapeutics (CAPR) in Q1 2026: 62,353 shares worth $1.9M. The stake represents 0.01% of the portfolio and ranks #623 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in CAPR as recently as Q2 2025.

Rafferty Asset Management first reported a position in CAPR in Q4 2024 and has held it in 4 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Rafferty Asset Management held 62,353 shares of Capricor Therapeutics worth $1.9M as of Q1 2026.
  • Capricor Therapeutics was a new Rafferty Asset Management position in Q1 2026.
  • Capricor Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #623 holding.
  • Rafferty Asset Management first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.